Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors

Artificial bone graft substitutes, such as Calcibon, are becoming increasingly interesting as they do not cause donor site morbidity which is an advantage compared to autologous bone grafts. The aim of this study was to evaluate the efficacy and potential complications associated with the use of Cal...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesenbichler, Joerg, Maurer-Ertl, Werner, Bergovec, Marko, Holzer, Lukas A., Ogris, Kathrin, Leitner, Lukas, Leithner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431777/
https://www.ncbi.nlm.nih.gov/pubmed/28496119
http://dx.doi.org/10.1038/s41598-017-02048-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431777/
https://www.ncbi.nlm.nih.gov/pubmed/28496119
http://dx.doi.org/10.1038/s41598-017-02048-w

Ejemplares similares